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Abstract
Severe liver diseases are characterized by expansion of liver progenitor cells (LPC), which 
correlates with disease severity. However, the origin and role of LPC in liver physiology and in 
hepatic injury remains a contentious topic. We found that ductular reaction cells in human 
cirrhotic livers express hepatocyte nuclear factor 1 homeobox B (HNF1β). However, HNF1β 
expression was not present in newly generated epithelial cell adhesion molecule (EpCAM)-
positive hepatocytes. In order to investigate the role of HNF1β- expressing cells we used a 
tamoxifen-inducible Hnf1βCreER/R26RYfp/LacZ mouse to lineage-trace Hnf1β+ biliary duct cells 
and to assess their contribution to LPC expansion and hepatocyte generation. Lineage tracing 
demonstrated no contribution of HNF1β+ cells to hepatocytes during liver homeostasis in healthy 
mice or after loss of liver mass. After acute acetaminophen or carbon tetrachloride injury no 
contribution of HNF1β+ cells to hepatocyte was detected. We next assessed the contribution of 
Hnf1β+ -derived cells following two liver injury models with LPC expansion, a 
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diethoxycarbonyl-1,4-dihydrocollidin (DDC)-diet and a choline-deficient ethionine-supplemented 
(CDE)-diet. The contribution of Hnf1β+ cells to liver regeneration was dependent on the liver 
injury model. While no contribution was observed after DDC-diet treatment, mice fed with a 
CDE-diet showed a small population of hepatocytes derived from Hnf1β+ cells that were 
expanded to 1.86% of total hepatocytes after injury recovery. Genome-wide expression profile of 
Hnf1β+ -derived cells from the DDC and CDE models indicated that no contribution of LPC to 
hepatocytes was associated with LPC expression of genes related to telomere maintenance, 
inflammation, and chemokine signaling pathways.
Conclusion—HNF1β+ biliary duct cells are the origin of LPC. HNF1β+ cells do not contribute 
to hepatocyte turnover in the healthy liver, but after certain liver injury, they can differentiate to 
hepatocytes contributing to liver regeneration.
Liver injury from any etiology induces mature liver cells to proliferate in order to replace the 
damaged tissue, allowing the recovery of the parenchymal function. In most situations, this 
process takes place without a clear involvement of liver progenitor cells (LPCs).1,2 LPC 
expansion has been described in several liver diseases, and correlates with the degree of 
liver injury.3,4 We have recently shown that in alcoholic hepatitis LPC markers correlate 
with liver injury and predict short-term mortality.3 This observation raises the question 
whether LPC expansion is a marker of liver injury or an incomplete attempt to regenerate 
the damaged liver. Moreover, it highlights the need for identifying the pattern of liver injury 
that favors LPC contribution to liver regeneration.
Ductular reaction constitutes a heterogeneous population of proliferating cells ranging from 
cells expressing stem cell markers with an immature phenotype, to more committed cells 
with an intermediate hepatobiliary phenotype.5–8 One of the most widely investigated 
markers is epithelial cell adhesion molecule (EpCAM), which is expressed in ductular 
reaction cells but also in newly generated hepatocytes, suggesting that EpCAM-positive 
hepatocytes may derive from progenitor cells.2,9,10 Several studies have shown the capacity 
of LPC to differentiate in vitro to hepatocyte-like and cholangiocyte-like cells.10–13 
However, the role of LPC in liver diseases is not well understood and whether LPCs derive 
from the biliary compartment and how they contribute to liver homeostasis and repair is still 
controversial. Moreover, it is largely unknown how the environment within the injured liver 
influences LPC differentiation.3,14,15
Genetic lineage-tracing has become a gold standard to evaluate the contribution of any given 
cell type to cells that arise during organ development, tissue homeostasis or disease. Recent 
studies aimed at evaluating the contribution of LPC to liver regeneration using this strategy 
have yielded disparate results. Using a sex-determining region Y-box 9 (SOX9) lineage-
tracing model, Furuyama et al.16 showed an important contribution of SOX9 progeny to 
hepatocyte regeneration, supporting a model of liver homeostasis and regeneration based on 
a permanent supply of liver cells from LPC. By contrast, other recent studies showed that 
SOX9-positive embryonic ductal epithelium cells and osteopontin-labeled adult liver cells 
have the potential to give rise to transit-amplifying progenitor cells and mature hepatocytes, 
although to a much lesser extent.17,18 Moreover, lineage-tracing studies of markers not 
expressed in intact liver but in ductular reaction cells have shown the potential of LPC to 
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differentiate to hepatocytes and cholangiocytes.13,19,20 In summary, there are conflicting 
evidences concerning the possible contribution of biliary duct cells and LPC to hepatocyte 
regeneration in response to liver injury.
Hepatocyte nuclear factor (HNF)1β is a homeobox transcription factor that plays a pivotal 
role during organogenesis and regulates gene expression in the adult liver and other 
epithelial organs.21–23 In liver development, HNF1β is involved in the hepatobiliary 
specification of hepatoblasts to cholangiocytes, and it is strongly expressed throughout the 
embryonic and adult biliary epithelium.21–24 However, little is known about the expression 
of HNF1β during liver injury and regeneration, and particularly its expression in LPC.
In this study we traced HNF1β+ cells to assess the contribution of the biliary epithelium to 
LPC and hepatocytes during healthy liver homeostasis, liver regeneration, and in animal 
models of acute and repeated liver injury. We show that under physiological conditions, 
hepatocytes do not derive from HNF1β+ cells. Only after liver injury do adult HNF1β+ cells 
give rise to the expansion of cells with an LPC phenotype and to periportal hepatocytes. 
However, the population of HNF1β+ cell-derived hepatocytes is small under these 
experimental conditions, suggesting that LPC do not substantially contribute to liver 
parenchymal regeneration under most liver injury insults.
Materials and Methods
Human Biopsies and Samples
Liver tissue samples were obtained from fragments of normal tissue surrounding colon 
metastasis collected at the moment of liver resection or from explants from liver 
transplantation due to alcohol-induced liver cirrhosis. The study was approved by the Ethics 
Committee of the Hospital Clinic of Barcelona and all patients included in this study gave 
written informed consent.
Animal Protocols
Hnf1bCreER transgenic mice were generated and genotyped as previously described.25 
Mice were crossed with mice bearing Cre-inducible Rosa26R reporters LacZ (β-
galactosidase [β-GAL] or yellow fluorescent protein [YFP]). To induce Cre-recombination, 
12 to 24-week-old mice were treated with three tamoxifen (Sigma-Aldrich, St. Louis, MO) 
doses (20 mg, 20 mg, and 10 mg) by gavage over 1 week. Tamoxifen was dissolved at 100 
mg/mL in 0.9% NaCl and 10% ethanol absolute in order to facilitate sonication. All animal 
models of liver injury were started 1 week after the last tamoxifen treatment. Two control 
groups were used for each experimental setting: mice treated with tamoxifen without liver 
injury, and mice with liver injury but without tamoxifen treatment.
The animal models of liver injury used in this study were: acute acetaminophen (APAP) 
(Sigma-Aldrich); acute carbon tetrachloride injection (CCl4, Sigma-Aldrich); two-thirds 
partial hepatectomy (PH); 0.1% 3,5-diethoxycarbonyl-1,4-dihydro-collidin (DDC) diet26 
(Sigma-Aldrich); choline-deficient (MP Biomedicals, Santa Ana, CA) ethionine-
supplemented (0.15% in water, Sigma-Aldrich) (CDE) diet,27 and chronic CCl4 
administration. All experimental models are described in the Supporting Material.
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All animal experiments were approved by the Ethics Committee of Animal Experimentation 
of the University of Barcelona and were conducted in accordance with the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals.
Histochemical Procedures and Immunostaining
The staining procedure is described in the Supporting Material.
Isolation of YFP+ Cells
YFP+ cells were obtained by liver perfusion method followed by flow cytometry cell sorting 
from uninjured mice (n = 3), and from mice treated with a DDC (n = 3) or CDE diet (n = 3) 
for 3 weeks. A detailed procedure of isolation and following RNA extraction and gene 
expression analysis are described in the Supporting Material.
Statistical Analysis
Continuous variables were described as means (± standard error) and were compared using 
the Student t test. All statistical analyses were performed using SPSS v. 14.0 for Windows 
(Chicago, IL).
Results
Expression of HNF1β in Normal and Cirrhotic Human Livers
We first investigated the expression pattern of HNF1β in human liver tissue. HNF1β 
expression was restricted to biliary duct cells in healthy livers (Fig. 1A). Immunostaining of 
liver samples from patients with advanced alcoholic liver disease showed that ductular 
reaction cells were positive for HNF1β (Fig. 1B), whereas HNF1β was not expressed in 
mature hepatocytes as assessed by double staining of HEP PAR-1 and HNF1β (Fig. 1C,D). 
To further determine HNF1β expression in immature hepatocytes, we performed a double 
staining of HNF1β and EpCAM in healthy and alcohol-induced cirrhotic livers. Double-
positive HNF1β/EpCAM cells were detected in the biliary epithelia from healthy tissue and 
in ductular reaction cells from cirrhotic tissue (Fig. 1E,F). Importantly, EpCAM-positive 
hepatocytes did not show HNF1β expression (Fig. 1F) suggesting that immature hepatocytes 
lost the expression of biliary markers such as HNF1β, while still retaining the LPC marker 
EpCAM.
Tamoxifen Induction of Cre-Recombinase in Hnf1βCreER/R26R Mice
In order to assess the specificity of Cre expression in HNF1β+ biliary cells, Hnf1βCreER/
R26RYfp/LacZ mice were treated with tamoxifen and analyzed for Cre expression. The 
expression of Cre was assessed 16 hours posttamoxifen administration since Cre is 
transiently located in the nucleus for only 6–36 hours (Supporting Fig. 1A). Immunostaining 
analysis showed Cre expression restricted to the bile duct cells and colocalized with YFP 
expression (Supporting Fig. 1B). Importantly, Cre recombinase expression was restricted to 
HNF1β+ cells, with an 88.47 ± 4.5% of HNF1β+ cells also positive for Cre (Supporting Fig. 
1C). Moreover, a 98.35 ± 0.4% of HNF1β+ cells also showed expression of SOX9 
(Supporting Fig. 1D). Cre expression colocalized with KRT19 and A626 (Supporting Fig. 
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1E,F). An overdose of tamoxifen is known to generate liver damage that could induce 
ectopic expression of HNF1β and the reporter. Tamoxifen treatment induced a mild increase 
in aspartate transaminase levels (AST) 42 ± 5.2 U/L versus 95.4 ± 30.2 U/L and alanine 
transaminase levels (ALT) 36 ± 16.9 U/L versus 76.4 ± 28.8 U/L. However, 
immunostaining results demonstrate that tamoxifen did not induce the expression of HNF1β 
or CRE in HNF4α+ hepatocytes (Supporting Fig. 1G,H). Induction of reporter gene YFP or 
β-GAL showed a labeling efficiency of 28.7 ± 10% as assessed by KRT19/YFP or 
KRT19/β-GAL. These results indicate that the Hnf1βCreER/R26RYfp/LacZ model can be 
used to trace the fate of HNF1β+ biliary duct cells.
Contribution of HNF1β+ Cells to Hepatocyte Turnover During Normal Liver Homeostasis
To evaluate the contribution of HNF1β+ cells in a situation of normal liver homeostasis, 
mice were treated with tamoxifen and sacrificed 2 months later. We assessed the phenotype 
of the cellular progeny of HNF1β+ cells by performing double staining with the reporter 
gene β-GAL and cell lineage markers HNF4α and KRT19. As shown in Supporting Fig. 2, 
we failed to find any hepatocytes that stained with the reporter marker, indicating that 
HNF1β+ cells give rise to biliary cells but do not contribute to physiological hepatocyte 
turnover.
Contribution of HNF1β+ Cells to Liver Regeneration
To trace the fate of HNF1β+ cells in a model of liver regeneration, we performed a two-
thirds PH in Hnf1βCreERYfp mice (Fig. 2A). Before PH, expression of YFP was restricted 
to the biliary epithelia as shown by KRT19/YFP and HNF4α/YFP staining (Fig. 2B). At 7 
days after surgery mice showed a ductular reaction with HNF1β+ cells restricted to bile 
ducts (Fig. 2C). Sporadic single hepatocytes located in periportal areas were positive for 
HNF4α and the reporter gene YFP (Fig. 2C). We also evaluated the contribution of HNF1β+ 
cells in mice at 28 days after surgery to allow the complete regeneration of the liver (Fig. 
2D). No contribution of HNF1β+ cells to hepatocytes was detected at 28 days after surgery, 
demonstrating that the biliary epithelium does not make a significant contribution to 
hepatocyte regeneration after PH.
Gene expression of Krt7, EpCAM, CD133, Trop2, and Krt199,28 was also evaluated in mice 
with PH at time 0 (excised liver), 7 days, and 28 days after surgery. As shown in Fig. 2E, 
gene expression of LPC markers was increased at 7 days compared to time 0 and returned to 
basal levels at 28 days. These results suggest that resolution of the liver regenerative process 
is accompanied with a reduction of cells with an LPC phenotype.
Fate of HNF1β+ Cells in Acute Liver Injury
In order to evaluate the proliferation and contribution of HNF1β+ cells after acute liver 
injury, we used two well-known models of acute damage, acute APAP and acute CCl4 
administration (Fig. 3A). As shown in Fig. 3B–D,F–H, dual staining of KRT19/YFP, SOX9/
YFP, and A6/YFP showed a mild induction of LPC expansion. Moreover, no duct-derived 
hepatocyte generation was observed based on dual staining of HNF4α/YFP (Fig. 3E,I).
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Contribution of Hnf1β+ Cells to Chronically Damaged Livers
LPC expansion is associated with liver damage compromising hepatocyte proliferative 
capacity. To determine the contribution of HNF1β+ cells to LPC expansion and hepatocyte 
regeneration, we performed three different types of chronic liver injury: a DDC diet, which 
induces cholangiocytic injury, as well as chronic CCl4 treatment and a CDE diet, both 
known for their hepatocyte toxic effect.
We first investigated the progeny of HNF1β+ cells in a DDC diet model, which typically 
stimulates progenitor cell proliferation (Fig. 4A). As expected, after 4 weeks of DDC diet an 
important ductular reaction was observed accompanied by a significant increase in Krt7, 
CD133, and Trop2 messenger RNA (mRNA) expression, but not in EpCAM and Krt19 (Fig. 
4B). Double immunostaining with LPC marker A6 or biliary markers SOX9 or KRT19 
together with the reporter gene β-GAL, and also EpCAM/HNF1β staining demonstrated that 
the ductular reaction was derived from HNF1β+ cells (Fig. 4C–G). However, no contribution 
of HNF1β+ cell progeny to hepatocytes was observed (Fig. 4H). We then explored if a DDC 
injury-recovery model enhanced the contribution of HNF1β+ cells to new hepatocytes. The 
replacement of the DDC diet (4 weeks) for standard chow (2 weeks) (DDC 4+2w) reduced 
the expression of LPC genes significantly (Fig. 4B), and double staining with HNF4α and β-
GAL did not show any contribution of HNF1β+ cells to hepatocyte generation (Supporting 
Fig. 3A–C).
Next, we assessed the contribution of Hnf1β+ cells in mice treated chronically with CCl4, 
which induces hepatocyte damage and liver fibrosis upon chronic treatment. After 8 weeks 
of CCl4 treatment, mice presented bridging fibrosis with marked deposition of extracellular 
matrix and areas of hepatocyte necrosis and inflammation (Supporting Fig. 3D–G). 
Although some expansion of LPC was noted as assessed by KRT19 staining, only sporadic 
single cells with double staining for HNF4α and β-GAL were observed (Supporting Fig. 
3E,F and data not shown). Although CCl4 induces hepatocyte damage, it did not 
compromise hepatocyte replication as shown by Ki-67 staining (Supporting Fig. 4). Thus, 
we next investigated the contribution of HNF1β+ cells to hepatocytes in a CDE model which 
presents hepatocyte damage, decreased hepatocyte proliferation, and LPC expansion (Fig. 
5A; Supporting Fig. 4). This LPC expansion was confirmed by an increase of LPC markers 
Krt7, EpCAM, CD133, and Krt19 after 3 weeks of CDE treatment, as shown in Fig. 5B. 
Moreover, there was a clear expansion of LPC derived from HNF1β+ cells as shown by A6 
(not shown), SOX9, and KRT19 double staining with YFP and EpCAM/HNF1β costaining 
(Fig. 5C). A 38.96% of KRT19+ cells coexpressed YFP. In addition, in this model we were 
able to identify a population of YFP+ hepatocytes in the periportal area as assessed by 
HNF4α/YFP staining (Fig. 5C). However, the number of HNF4α/YFP+ hepatocytes in this 
model was low (0.22% of total hepatocytes). We next explored if a CDE injury-recovery 
model enhanced the number of HNF1β-derived hepatocytes. Mice treated for 3 weeks with a 
CDE diet followed by 2 extra weeks with standard chow (CDE 3+2w), showed a strong 
ductular reaction, with cells coexpressing SOX9/YFP, EpCAM/HNF1β, and 53.84% 
KRT19/YFP double-positive cells (Fig. 5D). Moreover, this animal model had a reduced 
hepatocyte proliferation as assessed by Ki-67 staining and p21 expression (Supporting Fig. 
4). Importantly, we identified a double-positive population of HNF4α/YFP hepatocytes 
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representing 1.86% of the total hepatocyte population. Moreover, YFP+ hepatocytes were 
negative for HNF1β (Fig. 5D). These results indicate that at least a fraction of HNF1β+ cells 
are bipotential LPC with the capacity to give rise to cholangiocytes and hepatocytes.
Expression of LPC Markers in YFP+ Cells
In order to determine if HNF1β+ cells express LPC markers, YFP+ cells were isolated from 
uninjured mice and mice exposed to DDC and CDE diet. Genome-wide analysis showed 
that YFP+ cells from healthy and damaged livers expressed well-described LPC markers 
(Table 1). Moreover, they showed a mixed phenotype expressing genes typically expressed 
in hepatocytes such as HNF4α, Krt18, Onecut1, and Onecut2, Foxa2, and in cholangiocytes, 
Hnf1β, Muc1, and Krt19 (Table 1). Real-time polymerase chain reaction (PCR) of CD133, 
EpCAM, Trop2, CD24 Hnf1β, Sox9, and Krt19 was performed to validate the gene 
expression profile in DDC-YFP+ cells (data not shown). In order to investigate differences 
in gene expression profile in YFP+ cells from DDC and CDE-treated animals that could 
explain the differences in their contribution to hepatocyte generation, gene expression 
profiles were compared to YFP+ cells obtained from uninjured livers. As shown in Fig. 6, a 
Venn diagram showed that 280 genes were differentially expressed in CDE-derived YFP+ 
cells and 673 were found deregulated in DDC-derived YFP+ cells as compared with YFP+ 
cells from uninjured mice. We next performed a functional analysis of those genes 
differentially expressed in DDC and CDE-derived YFP+ cells (Fig. 6; Supporting Fig. 5 and 
Supporting Tables 4 and 5). Canonical pathways overrepresented in both DDC and CDE-
derived YFP+ cells showed an enrichment of up-regulated genes related to cell cycle, 
proliferation, p53 pathway, and cycle checkpoints. Interestingly, YFP+ cells from CDE and 
DDC diets showed important differences in terms of pathways overrepresented. On the one 
hand, as shown in Supporting Table 4, CDE treatment enhanced the expression of 
transcription factors and genes related to apoptosis and down-regulate genes involved in cell 
junction, cell-cell communication, Notch1, GSK3, or Wnt signaling pathway. On the other 
hand, gene set enrichment analysis of DDC YFP+ cells showed the up-regulation of genes 
related to telomere maintenance, inflammatory pathways, stress, and integrin pathways, and 
the down-regulation of genes related to lipid metabolism and synthesis, insulin-like growth 
factor or peroxisome proliferator activated receptor (PPAR) signaling (Supporting Fig. 5 and 
Supporting Tables 4 and 5). These results confirmed that HNF1β-derived cell population is 
enriched with LPC and provides information regarding which pathways may be responsible 
for the differences in contribution of HNF1β-derived cell to hepatocyte generation.
Discussion
The present study investigated the contribution of HNF1β+ cells from the biliary epithelium 
to liver regeneration. Importantly, we provide evidence that Hnf1β is expressed in cells 
forming the ductular reaction and expanded LPC in human diseases and in animal models of 
liver injury. We demonstrate that the HNF1β+ cell population express markers of LPC but 
does not contribute to normal parenchymal homeostasis; however, under liver injury, 
HNF1β+ cells expand and can give rise to hepatocytes. Nevertheless, our results suggest that 
the contribution of HNF1β+ cells to newly generated hepatocytes is low under most liver 
injury models.
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The main drawback of lineage tracing studies is the specificity of induction of the driving 
promoter. Regarding this point, the Hnf1βCreERYFP/LacZ mouse is an excellent tool to 
lineage trace ductular cells due to the specific expression of Hnf1β-Cre in the biliary tree 
cells and a complete absence of expression in other cell types.25 We carefully analyzed the 
expression of HNF1β, Cre-recombinase and the reporter genes YFP and β-GAL in intact 
livers and also after tamoxifen induction in order to show that recombination was taking 
place exclusively in biliary cells and not in periportal hepatocytes. This issue is particularly 
important in experimental settings where a low number of newly generated hepatocytes is 
expected.
Little is known about the role of HNF1β in liver injury and resolution.29 Recent studies 
showed that HNF1β participates in biliary tree formation, and HNF1β human deficiency is 
associated with ciliary defects in cholangiocytes.23,24,29,30 Here we demonstrate that HNF1β 
is expressed in progenitor cells, suggesting that it may also play a role in the maintenance of 
the hepatobiliary cell phenotype. Interestingly, HNF1β is expressed in human ductular 
reaction cells showing EpCAM expression but not in EpCAM-positive hepatocytes, 
suggesting that HNF1β expression in LPC may be lost upon differentiation. In this study we 
attempted to confirm this hypothesis by lineage tracing HNF1β+ cells.
The origin of LPC and its contribution to normal liver homeostasis and repair is still 
debated. Histological analyses have shown them in the vicinity of bile ducts6,31; thus, it has 
been suggested that LPC derive from the biliary compartment and participate in the 
generation of new cholangiocytes and hepatocytes. This hypothesis has been explored in 
recent studies of lineage tracing with SOX9 transcription factor and osteopontin. However, 
these important studies have yielded opposite results, partially due to reexpression of SOX9 
after tamoxifen induction16,17 and the use of nonendogenous artificial promoters.18 
Moreover, osteopontin is shown to be expressed in cell types other than progenitor cells 
(e.g., hepatic stellate cells32 and inflammatory cells33). This could be an important limitation 
of this study, since recent studies suggest that hepatic stellate cells can act as progenitor cells 
in the injured liver.34,35 By performing a lineage tracing based on HNF1β, a specific marker 
of cells from the biliary compartment, our study clearly demonstrates that during liver injury 
HNF1β+ biliary duct cells give rise to LPC, which have the potential to generate 
hepatocytes. However, hepatocyte generation may only occur under specific injury 
conditions and not as a default mechanism during liver homeostasis.
It is difficult to estimate the net contribution of HNF1β-derived hepatocytes to liver 
regeneration since the number of newly generated hepatocytes varies depending on the 
specific liver injury model or regenerative stimulus. Moreover, the labeling of HNF1β cells 
is not complete, so we may be underestimating the number of generated hepatocytes. Our 
results do not support the continuous nature of hepatocyte supply from the biliary 
compartment to liver parenchyma homeostasis and regeneration and is in line with the 
studies showing a modest contribution of LPC to hepatocyte regeneration only after specific 
liver damage.17,18 However, it is plausible that repeated cycles of injury-recovery or 
prolonged animal models of liver injury may show an increased significant level of 
contribution of LPC to liver regeneration. In this context, advanced chronic human diseases, 
which develop after prolonged periods of time (i.e., years), are characterized by a strong 
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hepatocyte arrest accompanied with a continuous and prolonged liver injury and 
inflammation.36 Differences in the type, duration, and severity of liver injury between 
experimental models and human diseases may also suggest that the contribution of LPC to 
liver regeneration in human chronic diseases may exceed the extent observed in animal 
models.
An important finding of our study is that gene expression levels of LPC markers does not 
correlate with LPC contribution to liver regeneration. The gene expression profile of total 
liver and HNF1β-derived YFP+ cells showed an enrichment of hepatobiliary and LPC 
markers, demonstrating that all animal models analyzed do induce LPC expansion. 
However, HNF1β-derived hepatocytes were observed only in the CDE animal model, and 
especially in the CDE injury-recovery model, suggesting that the liver injury milieu may 
influence the LPC differentiation capacity. Moreover, our study provides the first 
transcriptomic profile of mouse LPC comparing isolated cells from the two more widely 
used models of LPC expansion (i.e., DDC and CDE models). This analysis yielded 
important mechanistic data, since functional genome-wide analysis of YFP+ cells isolated 
from both animal models showed important differences in a number of pathways that may 
influence LPC differentiation. In that sense, YFP+ cells from DDC mice show an enrichment 
of genes related to inflammatory response, response to stress, telomerase maintenance, or 
cell cycle checkpoints that may be preventing HNF1β+ cells from differentiating. Further 
studies will need to evaluate which may be the involvement of these pathways in LPC 
expansion and differentiation.
LPC expansion and contribution to liver regeneration may have an important impact on liver 
disease since the degree of LPC activation correlates with survival in severe human liver 
disease such as alcoholic hepatitis.3 This observation suggests that in chronic liver diseases 
LPC expansion may be an uncontrolled response to injury that fails to effectively yield 
mature functioning hepatocytes. The data reported here provide important basic information 
regarding the adult biliary compartment as the origin of LPC. Although the lineage-tracing 
results shown here demonstrate that the biliary compartment may not play a role during 
normal liver homeostasis, it is clear that biliary cells give rise to an expanding LPC 
population with the potential to generate hepatocytes. Understanding the LPC contribution 
to hepatocyte generation is essential to better understand the mechanisms of liver 
regeneration and may have important implications for the development of new therapeutic 
strategies directed to enhance LPC expansion and differentiation aiming at favoring liver 
injury resolution.
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EpCAM epithelial cell adhesion molecule
HEP PAR-1 hepatocyte paraffin-1
HNF1β hepatocyte nuclear factor 1 homeobox B
HNF4α hepatocyte nuclear factor 4 alpha
Krt keratin
LPC liver progenitor cells
PH partial hepatectomy
SOX9 sex determining region Y-box 9
TROP2 tumor-associated calcium signal transducer 2
YFP yellow fluorescent protein
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HNF1β is expressed in biliary cells and in ductular reaction cells in healthy and diseased 
human liver. Representative images in healthy liver of (A) HNF1β immunostaining; (C) 
double immunostaining for HNF1β and hepatocyte marker HEP PAR-1; and (E) double 
immuno-staining for HNF1β and EpCAM. Representative pictures in cirrhotic liver of (B) 
HNF1β immunostaining; (D) double immunostaining for HNF1β and HEP PAR-1; and (F) 
double immunostaining for HNF1β and EpCAM. Nuclei counterstaining was performed 
with DAPI (blue) (magnification ×200 and ×400).
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HNF1β+ cells do not contribute to liver regeneration after partial hepatectomy. (A) Scheme 
of experimental design. Double immuno-staining with YFP and KRT19 (magnification 
×200) or HNF4α (magnification ×400) were performed at different timepoints: (B) Liver 
excised during PH (0d); (C) 7 days after PH (7d); and (D) 28 days after PH (28d). Few 
hepatocytes were double stained with HNF4α/YFP (white arrow). (E) Krt7, EpCAM, Trop2, 
CD133 and Krt19 gene expression in mice with partial hepatectomy (PH) at 7 days (PH 7d) 
(n = 4) or 28 days after surgery (PH 28d) (n = 4) compared to control liver (PH 0d) (n = 4) 
(*P < 0.05; **P < 0.005). Nuclei counterstaining was performed with DAPI (blue) 
(magnification ×200 and ×400). d; days; w, weeks before or after tamoxifen administration; 
PH, partial hepatectomy.
Rodrigo-Torres et al. Page 14














HNF1β+ cells do not contribute to hepatocyte regeneration in acute injury models. (A) 
Scheme of APAP and CCl4 single injection experimental design. Representative pictures of 
double staining with YFP and (B,F) KRT19, (C,G) SOX9, (D) HNF1β, (E,I) HNF4α, or (H) 
A6. HNF1β+ cells did not contribute to hepatocyte population after injury damage induced 
by (B–E) APAP administration or (F–I) CCl4 single injection. Nuclei counterstaining was 
performed with DAPI (blue) (magnification × 400). w, weeks before or after tamoxifen 
administration.
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HNF1β+ cells generate the ductular reaction but not hepatocytes in mice treated with a DDC 
diet. (A) Scheme of DDC diet experimental design. (B) Krt7, EpCAM, Trop2, CD133, and 
Krt19 gene expression in mice treated with a DDC diet for 4 weeks (n = 5) (DDC 4w) and 
DDC diet for 4 weeks plus standard chow for 2 weeks (DDC 4+2w) (n = 5) compared to 
uninjured mice liver (n = 4) (*P <0.05, **P<0.005). Representative images of double 
staining of β-GAL and (C) HNF1β, (D) KRT19, (E) SOX9, (F) A6, and (H) HNF4α, and 
(G) EpCAM/HNF1β in mice treated for 4 weeks with a DDC diet. Asterisks mark bile 
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deposits. w, weeks before or after DDC feeding; SC, standard chow; DDC, 3,5-
diethoxycarbonyl-1,4-dihydro-collidin. Nuclei counterstaining was performed with DAPI 
(blue) (magnification ×200 and ×400).
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HNF1β+ cells contribute to ductular reaction and hepatocyte regeneration in mice treated 
with a CDE diet. (A) Scheme of CDE diet experimental designs. (B) Krt7, EpCAM, Trop2, 
CD133, and Krt19 gene expression in mice treated with a CDE diet for 3 weeks (CDE 3w) 
(n = 3) and CDE injury-recovery model (CDE 3+2w) (n = 5) compared to uninjured mice 
liver (n = 4); (*P < 0.05; **P < 0.005). (C) Representative images of double staining of YFP 
and SOX9, HNF4α, KRT19, and EpCAM/HNF1β in mice treated for 3 weeks with a CDE 
diet. HNF1β-derived hepatocytes are indicated with white arrows. (D) Representative 
images of double staining of YFP and SOX9, HNF4α, KRT19, and EpCAM in mice treated 
for 3 weeks with a CDE diet and 2 weeks with standard chow (CDE 3+2w). Nuclei 
counterstaining was performed with DAPI (blue) (magnification ×200 and ×400). w, weeks 
after or before CDE feeding; SC, standard chow; CDE, choline-deficient ethionine-
supplemented.
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Venn diagram showing overlap of significantly regulated genes considering YFP+ cells 
isolated from CDE- and DDC-treated mice versus uninjured mice (CTRL). Genes were 
found regulated (fold-change <1.5 and >1.5 and moderated P < 0.05) after assessing 
significance using the LIMMA package.
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Table 1
Expression of Progenitor Markers in YFP+ Cells
Fold Change
Symbol Gene Name CDE DDC CTRL
Hnf1b HNF1 homeobox B 42.9 41.8 46.0
Sox9 SRY-box containing gene 9 37.5 36.4 38.0
Cldn7 claudin 7 28.6 27.1 29.5
Muc1 mucin 1, transmembrane 16.7 26.9 26.5
Krt19 keratin 19 21.0 24.5 26.0
Prom1 prominin 1 16.5 16.9 21.3
Krt8 keratin 8 19.2 25.2 20.8
Spp1 secreted phosphoprotein 1 21.1 22.2 20.1
Cldn3 claudin 3 17.2 20.5 19.5
Krt18 keratin 18 19.1 21.6 19.2
Onecut1 one cut domain, family member 1 18.0 18.0 17.0
Cdh1 cadherin 1 14.1 14.4 15.8
Onecut2 one cut domain, family member 2 17.9 16.5 15.8
Sox4 SRY-box containing gene 4 12.6 15.9 14.8
Krt7 keratin 7 11.4 17.4 14.6
Epcam epithelial cell adhesion molecule 14.6 15.1 13.5
Foxa1 forkhead box A1 14.1 11.7 12.0
Foxa3 forkhead box A3 9.3 5.6 7.9
Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 9.9 7.1 7.6
Cd24a CD24a antigen 7.2 8.0 6.9
Foxa2 forkhead box A2 5.2 5.1 5.5
Hnf4a hepatic nuclear factor 4, alpha 3.8 4.6 5.5
Tacstd2 tumor-associated calcium signal transducer 2 4.1 10.0 4.8
Ncam1 neural cell adhesion molecule 1 1.5 2.3 4.6
CDE, choline-deficient, ethionine-supplemented treated mice; DDC, 3,5-diethoxycarbonyl-1,4-dihydro-collidin treated mice; CTRL, uninjured 
mice.
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